Citations
T. Thaweethai et al. Building of a definition of postacute sequelae of SARS-CoV-2 an infection. JAMA. Vol. 22. Would possibly 25, 2023, p. 1934. doi: 10.1001/jama.2023.8823.
C. Greene et al. Blood–mind barrier disruption and sustained systemic irritation in people with lengthy COVID-associated cognitive impairment. Nature Neuroscience. Printed on-line February 22, 2024. doi:.1038/s41593-024-01576-9.
B. A. Krishna et al. Spontaneous, chronic, T cellular–dependent IFN-γ free up in sufferers who development to Lengthy Covid. Science Advances. Printed on-line February 21, 2024. doi: 10.1126/sciadv.adi9379.
K. Baillie et al. Supplement dysregulation is a prevalent and therapeutically amenable function of lengthy COVID. Med. Printed on-line February 14, 2024. doi: 10.1016/j.medj.2024.01.011.
C. Cervia-Hasler et al. Chronic supplement dysregulation with indicators of thromboinflammation in lively lengthy COVID. Science. Vol. 383. January 19, 2024. doi: 10.1126/science.adg7942.
K. Yin et al. Lengthy COVID manifests with T cellular dysregulation, irritation and an uncoordinated adaptive immune reaction to SARS-CoV-2. Nature Immunology. Vol. 25. January 11, 2024, p. 218. doi:10.1038/s41590-023-01724-6.
J. Klein et al. Distinguishing options of lengthy COVID recognized thru immune profiling. Nature. Vol. 623. September 25, 2023, p. 139. doi:10.1038/s41586-023-06651-y.
M.J. Peluso et al. Multimodal molecular imaging unearths tissue-based T cellular activation and viral RNA endurance for as much as 2 years following COVID-19. medRxiv.org. Posted July 31, 2023. doi: 10.1101/2023.07.27.23293177.
E.R. Praff et al. Coding lengthy COVID: characterizing a brand new illness thru an ICD-10 lens. BMC Drugs. Vol 21. February 16, 2023. doi: 10.1186/s12916-023-02737-6.
H.E. Davis et al. Lengthy COVID: main findings, mechanisms and suggestions. Nature Evaluations Microbiology. Vol 21. January 13, 2023, p. 133. doi: 10.1038/s41579-022-00846-2.
L. Au et al. Lengthy COVID and clinical gaslighting: Dismissal, not on time prognosis, and deferred remedy. SSM Qualitative Analysis in Well being. Vol. 2. December 2022, p. 100167. doi:10.1016/j.ssmqr.2022.100167.